发表年份

  • 1年内
  • 2年内
  • 3年内
  • 5年内
  • 10年内
  • 更早

产品或服务类型

  • 小鼠
  • 大鼠
  • 细胞
  • 斑马鱼
  • 技术服务
Tuning the fluidity and protein corona of ultrasound-responsive liposomal nanovaccines to program T cell immunity in mice

产品名称：C3-KO

研究领域：肿瘤及肿瘤免疫;T 细胞免疫

发表年份：2024 发表杂志：Nature Communications

SKAP1 Expression in Cancer Cells Enhances Colon Tumor Growth and Impairs Cytotoxic Immunity by Promoting Neutrophil Extracellular Trap Formation via the NFATc1/CXCL8 Axis

产品名称：M-NSG;BALB/c Nude

研究领域：肿瘤及肿瘤免疫;结肠肿瘤

发表年份：2024 发表杂志：Advanced Science

Lysosomal TFEB-TRPML1 Axis in Astrocytes Modulates Depressive-like Behaviors

产品名称：Mcoln1-Flox

研究领域：神经;抑郁样行为

发表年份：2024 发表杂志：Advanced Science

The WFS1-ZnT3-Zn2+ Axis Regulates the Vicious Cycle of Obesity and Depression

产品名称：Wfs1-Flox

研究领域：代谢心血管;肥胖与抑郁症之间关联

发表年份：2024 发表杂志：Advanced Science

A mouse protozoan boosts antigen-specific mucosal IgA responses in a specific lipid metabolism- and signaling-dependent manner

产品名称：Ltb4r1-KO

研究领域：代谢心血管;特定的脂质代谢增强抗原特异性粘膜IgA

发表年份：2024 发表杂志：Nature Communications

Targeting APT2 improves MAVS palmitoylation and antiviral innate immunity

产品名称：Zdhhc24-KO

研究领域：自身免疫及炎症;先天免疫

发表年份：2024 发表杂志：MOLECULAR CELL

Rationally designed BCR-ABL kinase inhibitors for improved leukemia treatment via covalent and pro-/dual-drug targeting strategies

产品名称：M-NSG

研究领域：肿瘤及肿瘤免疫;白血病

发表年份：2024 发表杂志：Journal of Advanced Research

A CD25×TIGIT bispecific antibody induces anti-tumor activity through selective intratumoral Treg cell depletion

产品名称：hIL2RA

研究领域：肿瘤及肿瘤免疫;瘤内调节性 T 细胞 (Treg)

发表年份：2024 发表杂志：MOLECULAR THERAPY

YTHDF2 in peritumoral hepatocytes mediates chemotherapy-induced antitumor immune responses through CX3CL1-mediated CD8+ T cell recruitment

产品名称：Ythdf2-Flox

研究领域：肿瘤及肿瘤免疫;瘤周肝细胞

发表年份：2024 发表杂志：Molecular Cancer

RGS5+ lymphatic endothelial cells facilitate metastasis and acquired drug resistance of breast cancer through oxidative stress-sensing mechanism

产品名称：Rgs5-KO

研究领域：肿瘤及肿瘤免疫;乳腺癌

发表年份：2024 发表杂志：DRUG RESISTANCE UPDATES

微信咨询 qrcode 请拨打 400 728 0660 在线咨询 回到顶部